The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy. Leuk Lymphoma. 2007 Oct; 48(10):1931-9.

View in: PubMed

subject areas

Adult
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antibodies, Neoplasm
Antineoplastic Agents
Drug Resistance, Neoplasm
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphatic Diseases
Male
Middle Aged
Models, Biological
Rituximab
Stem Cell Transplantation
Transplantation, Homologous
Treatment Outcome
Vidarabine

authors with profiles

ISSA F KHOURI
HAGOP M KANTARJIAN
ALESSANDRA FERRAJOLI
APOSTOLIA MARIA TSIMBERIDOU
WILLIAM G WIERDA